Redeye is lowering its forecasts and valuation for Opus in the wake of Covid-19. The company’s operations are impacted in multiple countries, and the financial market turbulence has reduced investor risk appetite. We are no longer sure that Searchlight will make a new bid above the one that expired in February (SEK 8.50). (This is an English translation of our update published earlier on May 18, 2020).